The Peptide Boundary Problem: Why GLP-1 Drugs, Compounded Medication, Research Peptides, and Longevity Claims Cannot Share One Funnel
A source-backed GLP-1 Intelligence Hub guide separating FDA-approved prescription drugs, compounded medication, investigational metabolic drugs, research-use peptides, longevity-clinic claims, and supplement/wellness products.
